Kistler Tiffany Companies LLC Sells 378 Shares of Lam Research Co. (NASDAQ:LRCX)

Kistler Tiffany Companies LLC reduced its holdings in Lam Research Co. (NASDAQ:LRCX) by 31.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 823 shares of the semiconductor company’s stock after selling 378 shares during the period. Kistler Tiffany Companies LLC’s holdings in Lam Research were worth $241,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. North Star Investment Management Corp. acquired a new stake in shares of Lam Research during the 3rd quarter worth approximately $150,000. Columbus Circle Investors acquired a new stake in shares of Lam Research during the 3rd quarter worth approximately $14,633,000. Boston Advisors LLC grew its holdings in shares of Lam Research by 5.6% during the 3rd quarter. Boston Advisors LLC now owns 102,394 shares of the semiconductor company’s stock worth $23,664,000 after purchasing an additional 5,441 shares in the last quarter. BB&T Corp grew its holdings in shares of Lam Research by 16.6% during the 3rd quarter. BB&T Corp now owns 67,070 shares of the semiconductor company’s stock worth $15,500,000 after purchasing an additional 9,555 shares in the last quarter. Finally, Bluefin Trading LLC acquired a new stake in shares of Lam Research during the 3rd quarter worth approximately $393,000. 86.63% of the stock is currently owned by institutional investors.

LRCX stock traded up $3.47 during trading on Tuesday, hitting $300.76. The company had a trading volume of 1,731,412 shares, compared to its average volume of 1,426,146. The company has a fifty day moving average price of $284.29 and a two-hundred day moving average price of $240.39. The company has a current ratio of 3.59, a quick ratio of 2.99 and a debt-to-equity ratio of 0.76. Lam Research Co. has a fifty-two week low of $136.65 and a fifty-two week high of $304.37. The company has a market cap of $43.13 billion, a P/E ratio of 20.67, a P/E/G ratio of 1.43 and a beta of 1.64.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings data on Wednesday, October 23rd. The semiconductor company reported $3.18 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.01 by $0.17. Lam Research had a return on equity of 43.11% and a net margin of 22.38%. The firm had revenue of $2.17 billion during the quarter, compared to the consensus estimate of $2.17 billion. During the same quarter in the previous year, the company posted $3.36 EPS. The business’s revenue for the quarter was down 7.1% compared to the same quarter last year. On average, analysts expect that Lam Research Co. will post 15.21 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 8th. Shareholders of record on Wednesday, December 11th were given a $1.15 dividend. The ex-dividend date of this dividend was Tuesday, December 10th. This represents a $4.60 annualized dividend and a yield of 1.53%. Lam Research’s payout ratio is 31.62%.

In other Lam Research news, CFO Douglas R. Bettinger sold 18,693 shares of Lam Research stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $279.03, for a total value of $5,215,907.79. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Timothy Archer sold 10,000 shares of Lam Research stock in a transaction on Friday, December 6th. The shares were sold at an average price of $270.00, for a total value of $2,700,000.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 73,576 shares of company stock valued at $20,803,977. Corporate insiders own 0.43% of the company’s stock.

LRCX has been the topic of several recent research reports. Credit Suisse Group reissued an “outperform” rating and set a $300.00 price objective (up previously from $278.00) on shares of Lam Research in a report on Thursday, October 24th. Zacks Investment Research lowered Lam Research from a “buy” rating to a “hold” rating and set a $273.00 price target on the stock. in a research note on Monday, October 14th. ValuEngine lowered Lam Research from a “hold” rating to a “sell” rating in a research note on Friday, January 3rd. Bank of America raised Lam Research from a “neutral” rating to a “buy” rating in a research note on Friday. Finally, Cowen boosted their price target on Lam Research from $235.00 to $290.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $264.79.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits worldwide. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition product for copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatment; SPEED gapfill high-density plasma chemical vapor deposition (CVD) products; Striker single-wafer atomic layer deposition (ALD) products; and VECTOR plasma-enhanced CVD ALD products.

Read More: How much money do you need to begin day trading?

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCX).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.